Brief: Nyxoah Provides Update On FDA Approvable Letter For Genio System
April 8 (Reuters) - Nyxoah SA NYXH.BR: NYXOAH PROVIDES UPDATE ON FDA APPROVABLE LETTER FOR GENIO SYSTEM NYXOAH SA - EXPECTS TO MEET FINAL FDA REQUIREMENTS FOR FULL PMA APPROVAL IN Q2 Source text: ID:nGNX5jCSLy Further company coverage: NYXH.BR ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nyxoah SA
See all newsBelgium's Nyxoah Q3 revenue rises on US commercialization
Brief: Nyxoah SA Q3 Gross Profit EUR 5.785 Million
Brief: Nyxoah SA Submits Pma Supplement To FDA To Expand Genio Indication To Complete Concentric Collapse Patients
Brief: Nyxoah Says Co Appoints Liam Kelly As Chief Executive Officer Effective October 1
Brief: Cvrx Appoints John Landry As Chief Financial Officer